Evaluation of the neurological safety of epidural milnacipran in rats

Seung Mo Lim, Mee Ran Shin, Kyung Ho Kang, Hyun Kang, Francis Sahngun Nahm, Baek-Hui Kim, Hwa Yong Shin, Young Jin Lim, Sang Chul Lee

Research output: Contribution to journalArticle

Abstract

Background: Milnacipran is a balanced serotonin norepinephrine reuptake inhibitor with minimal side effects and broad safety margin. It acts primarily on the descending inhibitory pain pathway in brain and spinal cord. In many animal studies, intrathecal administration of milnacipran is effective in neuropathic pain management. However, there is no study for the neurological safety of milnacipran when it is administered neuraxially. This study examined the neurotoxicity of epidural milnacipran by observing behavioral and sensory-motor changes with histopathological examinations of spinal cords in rats. Methods:Sixty rats were divided into 3 groups, with each group receiving epidural administration of either 0.3 ml (3 mg) of milnacipran (group M, n = 20), 0.3 ml of 40% alcohol (group A,n = 20), or 0.3 ml of normal saline (group S, n = 20). Results: There were no abnormal changes in the behavioral, sensory-motor, or histopathological findings in all rats of groups M and S over a 3-week observation period, whereas all rats in group A had abnormal changes. Conclusions: Based on these findings, the direct epidural administration of milnacipran in rats did not present any evidence of neurotoxicity in behavioral, sensory-motor and histopathological evaluations.

Original languageEnglish
Pages (from-to)228-237
Number of pages10
JournalKorean Journal of Pain
Volume25
Issue number4
DOIs
Publication statusPublished - 2012 Oct 1

Fingerprint

Safety
Spinal Cord
Neuralgia
Pain Management
milnacipran
Alcohols
Observation
Pain
Brain

Keywords

  • Epidural injection
  • Milnacipran
  • Neurotoxicity

ASJC Scopus subject areas

  • Anesthesiology and Pain Medicine

Cite this

Lim, S. M., Shin, M. R., Kang, K. H., Kang, H., Nahm, F. S., Kim, B-H., ... Lee, S. C. (2012). Evaluation of the neurological safety of epidural milnacipran in rats. Korean Journal of Pain, 25(4), 228-237. https://doi.org/10.3344/kjp.2012.25.4.228

Evaluation of the neurological safety of epidural milnacipran in rats. / Lim, Seung Mo; Shin, Mee Ran; Kang, Kyung Ho; Kang, Hyun; Nahm, Francis Sahngun; Kim, Baek-Hui; Shin, Hwa Yong; Lim, Young Jin; Lee, Sang Chul.

In: Korean Journal of Pain, Vol. 25, No. 4, 01.10.2012, p. 228-237.

Research output: Contribution to journalArticle

Lim, SM, Shin, MR, Kang, KH, Kang, H, Nahm, FS, Kim, B-H, Shin, HY, Lim, YJ & Lee, SC 2012, 'Evaluation of the neurological safety of epidural milnacipran in rats', Korean Journal of Pain, vol. 25, no. 4, pp. 228-237. https://doi.org/10.3344/kjp.2012.25.4.228
Lim, Seung Mo ; Shin, Mee Ran ; Kang, Kyung Ho ; Kang, Hyun ; Nahm, Francis Sahngun ; Kim, Baek-Hui ; Shin, Hwa Yong ; Lim, Young Jin ; Lee, Sang Chul. / Evaluation of the neurological safety of epidural milnacipran in rats. In: Korean Journal of Pain. 2012 ; Vol. 25, No. 4. pp. 228-237.
@article{fdb1e4f6877f47729842f499c64f3739,
title = "Evaluation of the neurological safety of epidural milnacipran in rats",
abstract = "Background: Milnacipran is a balanced serotonin norepinephrine reuptake inhibitor with minimal side effects and broad safety margin. It acts primarily on the descending inhibitory pain pathway in brain and spinal cord. In many animal studies, intrathecal administration of milnacipran is effective in neuropathic pain management. However, there is no study for the neurological safety of milnacipran when it is administered neuraxially. This study examined the neurotoxicity of epidural milnacipran by observing behavioral and sensory-motor changes with histopathological examinations of spinal cords in rats. Methods:Sixty rats were divided into 3 groups, with each group receiving epidural administration of either 0.3 ml (3 mg) of milnacipran (group M, n = 20), 0.3 ml of 40{\%} alcohol (group A,n = 20), or 0.3 ml of normal saline (group S, n = 20). Results: There were no abnormal changes in the behavioral, sensory-motor, or histopathological findings in all rats of groups M and S over a 3-week observation period, whereas all rats in group A had abnormal changes. Conclusions: Based on these findings, the direct epidural administration of milnacipran in rats did not present any evidence of neurotoxicity in behavioral, sensory-motor and histopathological evaluations.",
keywords = "Epidural injection, Milnacipran, Neurotoxicity",
author = "Lim, {Seung Mo} and Shin, {Mee Ran} and Kang, {Kyung Ho} and Hyun Kang and Nahm, {Francis Sahngun} and Baek-Hui Kim and Shin, {Hwa Yong} and Lim, {Young Jin} and Lee, {Sang Chul}",
year = "2012",
month = "10",
day = "1",
doi = "10.3344/kjp.2012.25.4.228",
language = "English",
volume = "25",
pages = "228--237",
journal = "Korean Journal of Pain",
issn = "2005-9159",
publisher = "The Korean Pain Society",
number = "4",

}

TY - JOUR

T1 - Evaluation of the neurological safety of epidural milnacipran in rats

AU - Lim, Seung Mo

AU - Shin, Mee Ran

AU - Kang, Kyung Ho

AU - Kang, Hyun

AU - Nahm, Francis Sahngun

AU - Kim, Baek-Hui

AU - Shin, Hwa Yong

AU - Lim, Young Jin

AU - Lee, Sang Chul

PY - 2012/10/1

Y1 - 2012/10/1

N2 - Background: Milnacipran is a balanced serotonin norepinephrine reuptake inhibitor with minimal side effects and broad safety margin. It acts primarily on the descending inhibitory pain pathway in brain and spinal cord. In many animal studies, intrathecal administration of milnacipran is effective in neuropathic pain management. However, there is no study for the neurological safety of milnacipran when it is administered neuraxially. This study examined the neurotoxicity of epidural milnacipran by observing behavioral and sensory-motor changes with histopathological examinations of spinal cords in rats. Methods:Sixty rats were divided into 3 groups, with each group receiving epidural administration of either 0.3 ml (3 mg) of milnacipran (group M, n = 20), 0.3 ml of 40% alcohol (group A,n = 20), or 0.3 ml of normal saline (group S, n = 20). Results: There were no abnormal changes in the behavioral, sensory-motor, or histopathological findings in all rats of groups M and S over a 3-week observation period, whereas all rats in group A had abnormal changes. Conclusions: Based on these findings, the direct epidural administration of milnacipran in rats did not present any evidence of neurotoxicity in behavioral, sensory-motor and histopathological evaluations.

AB - Background: Milnacipran is a balanced serotonin norepinephrine reuptake inhibitor with minimal side effects and broad safety margin. It acts primarily on the descending inhibitory pain pathway in brain and spinal cord. In many animal studies, intrathecal administration of milnacipran is effective in neuropathic pain management. However, there is no study for the neurological safety of milnacipran when it is administered neuraxially. This study examined the neurotoxicity of epidural milnacipran by observing behavioral and sensory-motor changes with histopathological examinations of spinal cords in rats. Methods:Sixty rats were divided into 3 groups, with each group receiving epidural administration of either 0.3 ml (3 mg) of milnacipran (group M, n = 20), 0.3 ml of 40% alcohol (group A,n = 20), or 0.3 ml of normal saline (group S, n = 20). Results: There were no abnormal changes in the behavioral, sensory-motor, or histopathological findings in all rats of groups M and S over a 3-week observation period, whereas all rats in group A had abnormal changes. Conclusions: Based on these findings, the direct epidural administration of milnacipran in rats did not present any evidence of neurotoxicity in behavioral, sensory-motor and histopathological evaluations.

KW - Epidural injection

KW - Milnacipran

KW - Neurotoxicity

UR - http://www.scopus.com/inward/record.url?scp=84873529393&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84873529393&partnerID=8YFLogxK

U2 - 10.3344/kjp.2012.25.4.228

DO - 10.3344/kjp.2012.25.4.228

M3 - Article

VL - 25

SP - 228

EP - 237

JO - Korean Journal of Pain

JF - Korean Journal of Pain

SN - 2005-9159

IS - 4

ER -